Free tool
Diagnostics stocks
We cover 5 companies grouped under the Diagnostics theme. The median market value in the group is $14.63B. Across the group, the median move over the past trading day is +0.58%. Price change over the past year runs from −26.3% to +105.4% across the middle 80 percent of the group, with a median of +11.0%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
5 of 150 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| GH | Guardant Health, Inc. | $164.92 | +13.37% | +62.10% | +166.52% |
| ERF.PA | Eurofins Scientific SE | 73.26 EUR | +6.92% | +19.56% | +13.76% |
| ESF0.DE | Eurofins Scientific SE | 72.70 EUR | +6.29% | +17.51% | +11.02% |
| TEM | Tempus AI, Inc. | $68.73 | +60.17% | +10.21% | −9.45% |
| BIM.PA | bioMérieux S.A. | 74.35 EUR | −0.80% | −32.10% | −37.52% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.